Advertisement

Indian Journal of Clinical Biochemistry

, Volume 25, Issue 1, pp 77–81 | Cite as

Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder

  • Kiran ChaudhariEmail author
  • S. Khanzode
  • S. Khanzode
  • G. Dakhale
  • A. Saoji
  • S. Sarode
Original Article

Abstract

Derangement of antioxidant levels in major depressive disorder had been correlated with oxidative damage. The effect of Selective Serotonin Re-Uptake Inhibitors on endogenous antioxidant uric acid levels in major depressive disorder has never been examined. This was a prospective; open labeled, parallel, 12 weeks study, in which serum uric acid levels and Hamilton Rating Scale for Depression score were estimated in age and sex matched thirty-six healthy and forty major depressive disorder subjects before and after fluoxetine and citalopram treatment. Significant decrease in serum uric acid (P<0.0001) was observed in newly diagnosed major depressive disorder subjects when compared to healthy subjects. The trend was reversed after 6 weeks more significantly after 12 weeks of treatment with improvement in Hamilton Rating Scale for Depression score. Also, Significant and negative correlation was found between Hamilton Rating Scale for Depression score and serum uric acid level (r= −0.864, P<0.001) after 12 weeks of treatment. Treatment with fluoxetine or citalopram reverses endogenous antioxidants like uric acid and improves Hamilton Rating Scale for Depression score in major depressive disorder.

Key Words

Uric acid Citalopram Fluoxetine Hamilton Rating Scale for Depression score Major depression Selective Serotonin Re-Uptake Inhibitors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    MENTAL HEALTH Regional Committee for the Eastern Mediterranean Forty-eighth Session Riyadh, Saudi Arabia, 30 September — 3 October 2001 Accessed from: http://www.emro.who.int/RC48/RC48INFDOC1.htm Accessed on: 23rd OCT 2005.
  2. 2.
    Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palsodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Report 2003; 8(6): 365–370.CrossRefPubMedGoogle Scholar
  3. 3.
    Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alteration by antidepressant treatments. J Affect Dis 2001; 64: 43–51.CrossRefPubMedGoogle Scholar
  4. 4.
    Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000; 48: 755–765.CrossRefPubMedGoogle Scholar
  5. 5.
    Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004; 19(2): 89–95.CrossRefPubMedGoogle Scholar
  6. 6.
    Sen CK. Oxygen toxicity and antioxidants: state of the art. Ind J Physiol Pharmacol 1995; 39(3): 177–196.Google Scholar
  7. 7.
    Singh RP, Sharad S, Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. JIACM 2004;5(3): 218–225.Google Scholar
  8. 8.
    Kane P. Understanding the biochemical and biobehavioral nexus of depression. Nutritonal Research 1997; Explore issue, vol. 8(1). Accessed from: http://www.explorepub.com/articles/nutrition2.html Accessed on 23rd Jan 2005.
  9. 9.
    Maes M, Wauters A, Neels H, Scharpe S, Gastel AV, D’Hondt P, et al. Total serum protein and serum protein fractions in depression: relationship to depressive symptoms and glucocorticoid activity. J Affect Dis 1995; 34: 61–69.CrossRefPubMedGoogle Scholar
  10. 10.
    Yanik E, Erel O, Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 2004; 16: 200–203.CrossRefGoogle Scholar
  11. 11.
    Koo JR, Yoon JY, Joo MH, Lee HS, Oh JE, Kim SG, et al. Treatment of depression and effect of antidepressant on nutritional status in chronic hemodialysis patients. Am J Med Sci 2005; 329(1): 1–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Catalano MC, Catalano G, Kanfer SN, Toner LC, Stock SL, Tayler WD. The effect of sertraline on routine blood chemistry values. Clin Neuropharmacol 2000; 23 (5): 267–270.CrossRefPubMedGoogle Scholar
  13. 13.
    Stahl SM. Antidepressants and mood stabilizers. In: Essential psychopharmacology neuroscientific basis and practical application. New Delhi: Foundation books (Cambridge University Presss); 1998. pp. 131–166.Google Scholar
  14. 14.
    Yao JK, Reddy R, Kammen DP. Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Res 1998; 80: 29–39.CrossRefPubMedGoogle Scholar
  15. 15.
    Kharb S, Singh V. Total free radical trapping antioxidant potential in normal pregnancy. J Obstet Gynecol Ind 2004; 54(3): 249–250.Google Scholar
  16. 16.
    Rodionov RN. Urate as an endogenous antioxidant. Free Radicals in Biology and Medicine 2003; 77(222): 1–11.Google Scholar
  17. 17.
    Yao JK, Leonard S, Reddy RD. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull 2004; 30(4): 923–934.PubMedGoogle Scholar
  18. 18.
    Teng RJ, Ye YZ, Parks DA, Beckman JS. Urate produced during hypoxia protects heart proteins from peroxynitrite mediated protein nitration. Free Radic Biol Med 2002; 33(9): 1243–1249.CrossRefPubMedGoogle Scholar
  19. 19.
    Anderson RF, Harris TA. Dopamine and uric acid acts as antioxidants in the repair of DNA radicals: implications in Parkinson’s disease. Free Radic Res 2003; 37(10): 1131–1136.CrossRefPubMedGoogle Scholar
  20. 20.
    Li XM, Chlan FJ, Juorio AV, Bennett VL, Shrikhande S, Bowen RO. Antidepressants up regulate m-RNA levels of the neuroprotetcive enzyme, superoxide dismutase. J Psychiatr Neurosci 2000; 25: 43–47.Google Scholar

Copyright information

© Association of Clinical Biochemists of India 2010

Authors and Affiliations

  • Kiran Chaudhari
    • 1
    • 6
    Email author
  • S. Khanzode
    • 2
  • S. Khanzode
    • 1
  • G. Dakhale
    • 5
  • A. Saoji
    • 3
  • S. Sarode
    • 4
  1. 1.Department of PharmacologyGovernment Medical College NagpurMaharashtraIndia
  2. 2.Department of MedicineGovernment Medical College NagpurMaharashtraIndia
  3. 3.Department of PsychiatryGovernment Medical College NagpurMaharashtraIndia
  4. 4.Department of PhysiologyGovernment Medical College NagpurMaharashtraIndia
  5. 5.Department of PharmacologyIndira Gandhi Government Medical CollegeNagpurIndia
  6. 6.Plot No: 66Saraswati SocietyDeendayal Nagar, NagpurIndia

Personalised recommendations